Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaolin Huang

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Clinical & Translational Immunology|March 17, 2021
Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity - a cohort studyJingyi Yang, Maohua Zhong, Ke Hong, et al.
Journal of Molecular Cell Biology|March 22, 2021
Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19Jingyi Yang, Maohua Zhong, Ejuan Zhang, et al.
National Science Review|December 8, 2021
Post-mortem tissue proteomics reveals the pathogenesis of multi-organ injuries of COVID-19Yang Qiu, Di Wu, Wanshan Ning, et al.
Journal of Medical Virology|April 10, 2025
Proteomic Analysis of 442 Clinical Plasma Samples From Individuals With Symptom Records Revealed Subtypes of Convalescent Patients Who Had COVID-19Jiangfeng Liu, Li Guo, Jingchuan Zhong, et al.
Frontiers of Medicine|July 5, 2020
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysisJiuyang Xu, Chaolin Huang, Guohui Fan, et al.
Chest|March 2, 2024
Effect of Corticosteroids on Long-Term Humoral and Memory T-Cell Responses in Follow-Up Visit of Hospitalized Patients With COVID-19Yeming Wang, Li Guo, Guohui Fan, et al.
Emerging Microbes & Infections|November 16, 2023
Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in ChinaYing Liu, Jiayou Zhang, Wen Liu, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Impact of corticosteroids on initiation and half-year durability of humoral response in COVID-19 survivorsYeming Wang, Li Guo, Guohui Fan, et al.
The Lancet. Oncology|June 2, 2020
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort studyKunyu Yang, Yuhan Sheng, Chaolin Huang, et al.
Frontiers in Medicine|January 11, 2021
A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory FailureJiqian Xu, Xiaobo Yang, Chaolin Huang, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Clinical & Translational Immunology|March 17, 2021
Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity - a cohort studyJingyi Yang, Maohua Zhong, Ke Hong, et al.
Journal of Molecular Cell Biology|March 22, 2021
Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19Jingyi Yang, Maohua Zhong, Ejuan Zhang, et al.
National Science Review|December 8, 2021
Post-mortem tissue proteomics reveals the pathogenesis of multi-organ injuries of COVID-19Yang Qiu, Di Wu, Wanshan Ning, et al.
Journal of Medical Virology|April 10, 2025
Proteomic Analysis of 442 Clinical Plasma Samples From Individuals With Symptom Records Revealed Subtypes of Convalescent Patients Who Had COVID-19Jiangfeng Liu, Li Guo, Jingchuan Zhong, et al.
Frontiers of Medicine|July 5, 2020
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysisJiuyang Xu, Chaolin Huang, Guohui Fan, et al.
Chest|March 2, 2024
Effect of Corticosteroids on Long-Term Humoral and Memory T-Cell Responses in Follow-Up Visit of Hospitalized Patients With COVID-19Yeming Wang, Li Guo, Guohui Fan, et al.
Emerging Microbes & Infections|November 16, 2023
Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in ChinaYing Liu, Jiayou Zhang, Wen Liu, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Impact of corticosteroids on initiation and half-year durability of humoral response in COVID-19 survivorsYeming Wang, Li Guo, Guohui Fan, et al.
The Lancet. Oncology|June 2, 2020
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort studyKunyu Yang, Yuhan Sheng, Chaolin Huang, et al.
Frontiers in Medicine|January 11, 2021
A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory FailureJiqian Xu, Xiaobo Yang, Chaolin Huang, et al.
Pageof 9